H. Fiegl
发表
M. Rupp,
J. Hagenbuchner,
B. Rass,
2017,
Oncogene.
Martin Widschwendter,
Peter A. Jones,
Christian Marth,
2004,
Cancer Research.
H. Kitchener,
A. Teschendorff,
I. Jacobs,
2012,
PLoS genetics.
R. Micura,
Marie F. Soulière,
H. Fiegl,
2013,
RNA biology.
H. Kitchener,
A. Teschendorff,
M. Widschwendter,
2012,
Genome Medicine.
P. Laird,
D. Weisenberger,
I. Jacobs,
2007,
Nature Genetics.
HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer
Brooke L. Fridley,
Hugo M. Horlings,
Andrew E. Teschendorff,
2015,
Genome Medicine.
Peter W. Laird,
Martin Widschwendter,
Christian Marth,
2004,
Cancer Research.
H. Fiegl,
C. Marth,
E. Mueller-Holzner,
2006,
Anticancer research.
Martin Widschwendter,
Christian Marth,
Peter W Laird,
2006,
Cancer research.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Gynecologic oncology.
H. Fiegl,
C. Marth,
E. Müller-Holzner,
2004,
American journal of obstetrics and gynecology.
E. Kremmer,
H. Fiegl,
S. Hofer,
2003,
The EMBO journal.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Annals of the New York Academy of Sciences.
J. Hatina,
H. Fiegl,
C. Marth,
2018,
Journal of Cancer Research and Clinical Oncology.
H. Klocker,
H. Fiegl,
A. Zeimet,
2016,
Oncoscience.
Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
P. Altevogt,
H. Fiegl,
E. Müller-Holzner,
2013,
BMC Cancer.
R. Zeillinger,
H. Ulmer,
U. Moll,
2012,
International Journal of Gynecologic Cancer.
H. Fiegl,
C. Marth,
A. Zeimet,
2005,
Clinical Cancer Research.
H. Fiegl,
A. Villunger,
M. Drach,
2012,
Cell Death and Differentiation.
T. Mould,
M. Widschwendter,
H. Fiegl,
2013,
International Journal of Gynecologic Cancer.
R. Zeillinger,
H. Fiegl,
N. Concin,
2022,
Frontiers in Oncology.
D. Fuchs,
H. Fiegl,
N. Concin,
2010,
Cancer Immunology, Immunotherapy.
H. Fiegl,
N. Concin,
C. Marth,
2009,
International journal of cancer.
J. Hatina,
H. Fiegl,
N. Concin,
2012
.
W. Parson,
H. Fiegl,
R. Margreiter,
2007,
Cancer letters.
M. Widschwendter,
H. Fiegl,
H. Müller,
2003,
British Journal of Cancer.
M. Widschwendter,
H. Fiegl,
H. Müller,
2003,
Cancer research.
H. Fiegl,
A. Villunger,
H. Reichardt,
2019,
Front. Immunol..
R. Nicholson,
R. Sutherland,
E. Musgrove,
2012,
PloS one.
C. Fauth,
H. Fiegl,
K. Wimmer,
2015,
European Journal of Human Genetics.
G. Hartmann,
H. Fiegl,
C. Marth,
2019,
International journal of cancer.
P. Altevogt,
H. Fiegl,
C. Marth,
2016,
Oncotarget.
A. Hackethal,
H. Fiegl,
D. Brennan,
2015,
BMC Cancer.
H. Fiegl,
H. Müller,
R. Margreiter,
2007,
International Journal of Colorectal Disease.
Martin Widschwendter,
Helmut Klocker,
Christian Marth,
2005,
Cancer research.
Martin Widschwendter,
Matthias Lechner,
Georg Goebel,
2008,
International journal of cancer.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
The Lancet.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Clinical Cancer Research.
P. Altevogt,
S. Skvortsov,
H. Fiegl,
2010,
Cancer research.
R. Zeillinger,
H. Fiegl,
N. Concin,
2010,
Oncogene.
Andrew E. Teschendorff,
Martin Widschwendter,
Allison Jones,
2013,
PLoS medicine.
H. Brenner,
D. Rothenbacher,
I. Jacobs,
2008,
PloS one.
M. Widschwendter,
M. Ehrlich,
E. Fiala,
2004,
Cancer biology & therapy.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
H. Fiegl,
E. Müller-Holzner,
N. Rooijen,
2014,
European journal of immunology.
H. Fiegl,
C. Marth,
A. Zeimet,
2020,
Scientific Reports.
H. Fiegl,
C. Marth,
A. Zeimet,
2019,
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
H. Hackl,
H. Fiegl,
G. Goebel,
2016,
BMC Cancer.
Robin L. Jones,
M. Dowsett,
I. Jacobs,
2008,
Clinical Cancer Research.
M. Widschwendter,
E. Schuuring,
A. V. D. Van Der Zee,
2017,
BMC Medicine.
P. Altevogt,
H. Sültmann,
R. Zeillinger,
2014,
Oncotarget.
S. Reed,
S. Apostolidou,
M. Widschwendter,
2007,
Cancer research.
P. Altevogt,
R. Blaheta,
H. Fiegl,
2014,
Cancer letters.
Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Clinical chemistry.
B. Scarpellini,
A. Carvalho,
H. Fiegl,
2018,
Oncotarget.
I. Jacobs,
U. Menon,
M. Burnell,
2010,
Breast Cancer Research and Treatment.
H. Fiegl,
K. Elmasry,
2007,
Disease markers.
B. Meister,
M. Rupp,
J. Hagenbuchner,
2012,
Molecular biology of the cell.
S. Reed,
M. Widschwendter,
H. Fiegl,
2006,
Cancer research.
H. Fiegl,
A. Villunger,
M. Drach,
2012,
Cell Death and Differentiation.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Clinical Cancer Research.
S. Reed,
M. Widschwendter,
H. Fiegl,
2004,
Oncogene.
Pornpimol Charoentong,
Z. Trajanoski,
F. Révillion,
2014,
BMC Cancer.
H. Fiegl,
C. Marth,
A. Zeimet,
2016,
BMC Cancer.
R. Nicholson,
M. Widschwendter,
H. Fiegl,
2009
.
P. Altevogt,
S. Skvortsov,
H. Fiegl,
2011,
Oncogene.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Clinical chemistry.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
International journal of cancer.
H. Fiegl,
J. Sehouli,
A. Zeimet,
2015,
Oncotarget.
M. Widschwendter,
H. Fiegl,
H. Müller,
2004,
Cancer letters.
H. Kitchener,
A. Teschendorff,
M. Widschwendter,
2012,
Genome Medicine.
M. Widschwendter,
H. Fiegl,
P. Obexer,
2010,
Cancer science.
H. Fiegl,
G. Bonn,
G. Goebel,
2012,
International journal of molecular sciences.
M. Ehrlich,
H. Fiegl,
C. Marth,
2011,
Gynecologic oncology.
H. Fiegl,
C. Marth,
E. Müller-Holzner,
2004
.
Ian G. Reddin,
Nerissa K. Kirkwood,
S. Henderson,
2020
.
Inger Vikholm-Lundin,
Tony Munter,
Sanna Auer,
2009
.
H. Kitchener,
A. Teschendorff,
I. Jacobs,
2012,
PLoS Genetics.
P. Altevogt,
H. Fiegl,
N. Concin,
2016,
BMC Cancer.
M. Widschwendter,
H. Fiegl,
H. Müller,
2005,
Methods of Information in Medicine.
Thomas Schabetsberger,
Georg Goebel,
Karl P. Pfeiffer,
2009,
MIE.
H. Fiegl,
C. Marth,
S. Fessler,
2012,
Gynecologic oncology.
H. Fiegl,
Chetana Basavaraj,
V. Peg,
2022,
Breast.
H. Fiegl,
C. Marth,
A. Zeimet,
2016
.
U. Siebert,
H. Fiegl,
C. Marth,
2017,
Journal of comparative effectiveness research.
M. Widschwendter,
W. Parson,
S. Schmidt,
2011,
British Journal of Cancer.
H. Fiegl,
C. Marth,
A. Zeimet,
2016,
BMC Cancer.
Ruth M. Pfeiffer,
Heidi Fiegl,
Laurin A. J. Mueller,
2011,
Journal of Clinical Bioinformatics.
J. Hatina,
H. Fiegl,
N. Concin,
2012,
Neoplasma.
Ian G. Reddin,
Nerissa K. Kirkwood,
S. Henderson,
2020,
bioRxiv.
H. Hackl,
H. Fiegl,
G. Goebel,
2016,
BMC Cancer.
H. Fiegl,
C. Marth,
B. Böttcher,
2021,
Geburtshilfe und Frauenheilkunde.
Richard G. Jenner,
B. Fridley,
E. Goode,
2015
.
H. Fiegl,
C. Marth,
A. Soleiman,
2016,
Oncotarget.
H. Klocker,
M. Widschwendter,
H. Fiegl,
2005,
Cancer research.
I. Jacobs,
M. Widschwendter,
H. Fiegl,
2008,
International journal of cancer.